Skip to content

HydroSoft 3D 7110-0304-3D-A2Recalls & reported problems

Microvention, Inc. · V-Trak · Class 2 · Implant

All models of HydroSoft 3D (26)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00816777025456), received between Sep 6, 2023 and Nov 10, 2024 — classified as 2 injuries, 1 malfunction.

The most frequently reported specific device problem is “Component Missing” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 1 reportsOct 2024: 0 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Component Missing1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Aneurysm1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 10, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    AS REPORTED THROUGH THE RAGE CLINICAL STUDY: RECEIVED RETREATMENT DATA FROM THE STUDY TEAM FOR REVIEW. EVENT INFORMATION EVENT DATE: 04/NOV/2020 PROCEDURE DATE: (B)(6) 2019 TARGET ANEURYSM INFORMATION: ANEURYSM LOCATION: POSTERIOR COMMUNICATING (PCOM) OTHER ANEURYSM LOCATION: ANEURYSM SIDE: LEFT HEIGHT: 4.7MM WIDTH: 2.3MM DEPTH: 2.6MM NECK SIZE: 1.9MM DOME TO NECK RATIO: 1.21MM. EVENT DESCRIPTION: CEREBRAL ANGIOGRAPHY DEMONSTRATED COIL COMPACTION AND RECURRENCE AT THE BASE OF THE ANEURYSM. THE SUBJECT UNDERWENT RETREATMENT WITH CLIPPING. DEVICE INFORMATION THAT WAS USED IN INDEX PROCEDURE. AS IT CANNOT BE DETERMINED WHICH COIL DEVICE MAY HAVE IMPACTED THE ANEURYSM RECURRENCE THE HYDROSOFT 3D- 3X4 WAS CHOSEN AS A DEFAULT. THE OTHER COIL USED IN THE PROCEDURE WILL BE LISTED AS CONCOMITANT DEVICE. 1. HYDROSOFT 3D 3X4- DETACHED 2. HYDROSOFT 3D 1.5X2- DETACHED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20649469 ↗
  • InjurySep 2, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    AS REPORTED THROUGH THE RAGE CLINICAL STUDY: BELOW EVENT WAS REVIEWED BY INDEPENDENT REVIEWER (CEA) AND WAS DETERMINED TO BE DEFINITELY RELATED TO STUDY DEVICE AND PROBABLY RELATED TO STUDY PROCEDURE. EVENT INFORMATION: EVENT TERM: ANEURYSM RECURRENCE EVENT #: 2 EVENT START DATE: 20/FEB/2020 POST OPERATIVE DAYS: 211 DAYS EVENT DESCRIPTION : RECURRENCE ORIGINALLY FOUND 2/20/2020. DURING A CONSULT ON 1/15/2021 SUBJECT DISCUSSED RECURRENCE AND WANTING TREATMENT. SUBJECT HAD A 1.6 X 1.4 MM RECURRENCE AT THE BASE OF THIS ANEURYSM. PER TREATING PHYSICIAN THE RECURRENCE HAD A VERY LOW RISK OF RUPTURE. HOWEVER, THE PATIENT REPORTS DEBILITATING ANXIETY ABOUT FUTURE ANEURYSM-RELATED EVENTS THAT CULMINATED IN AN INPATIENT HOSPITALIZATION LAST MONTH FOLLOWING A SUICIDE ATTEMPT. DESPITE THE LOW NATURAL HISTORY RISK OF THE RECURRENT ANEURYSM, SUBJECT EXPRESSED THEY COULD NOT HANDLE THE THOUGHT OF GOING THROUGH ANOTHER ANEURYSM RUPTURE, AND THAT TAKING THE RISK OF ANEURYSM RUPTURE TO ZERO WOULD DRAMATICALLY IMPROVE ANXIETY. EMBOLIZATION PERFORMED ON (B)(6) 2021. FOLLOW UP ANGIOGRAM ON 10/8/2021 SHOWED COMPLETE OCCLUSION WITH NO RECURRENCE. AE OUTCOME : RESOLVED WITHOUT SEQUELAE DEVICES USED: HYDR

    Patient problems: Aneurysm

    MAUDE report 20116750 ↗
  • MalfunctionSep 6, 2023Component Missing; Component Missing

    SEE SECTION H10 FOR INVESTIGATION RESULTS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17695077 ↗

Other Device, Vascular, for Promoting Embolization devices

All Device, Vascular, for Promoting Embolization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page